Pharmacokinetic-guided versus weight-guided coagulation factor replacement in hemophilia patients undergoing arthroplasty: a retrospective real-world study on perioperative bleeding risk and economic outcomes - Top-Institutions - MDSpire

Pharmacokinetic-guided versus weight-guided coagulation factor replacement in hemophilia patients undergoing arthroplasty: a retrospective real-world study on perioperative bleeding risk and economic outcomes

  • By

  • Shuxia Zhang

  • Yi Chen

  • Haojie Qin

  • Jing Chen

  • Chunrong Chen

  • Xuemei Wu

  • Min Chen

  • Jiajun Lin

  • Fenge Yang

  • Meijuan Huang

  • July 14, 2026

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Fujian Medical University Union Hospital
    Fujian Medical University Union Hospital

    Fuzhou, Fujian

    Key Differentiators

    • Hematology

  • #2

    University Medical Center Utrecht
    University Medical Center Utrecht

    Utrecht, Utrecht

    Key Differentiators

    • Geriatrics

  • #3

    NHS Lothian
    NHS Lothian

    Edinburgh, Scotland

    Key Differentiators

    • Quality Improvement

  • #4

    Boston Children’s Hospital
    Boston Children’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Pediatric Cardiology

  • #5

    TriNetX Research Network
    TriNetX Research Network

    Cambridge, Massachusetts

    Key Differentiators

    • Health Data Research

Original Source(s)

Pharmacokinetic-guided versus weight-guided coagulation factor replacement in hemophilia patients undergoing arthroplasty: a retrospective real-world study on perioperative bleeding risk and economic outcomes

  • by Shuxia Zhang, Yi Chen, Haojie Qin, Jing Chen, Chunrong Chen, Xuemei Wu, Min Chen, Jiajun Lin, Fenge Yang, Meijuan Huang

  • July 14, 2026

Related Content

Bivalirudin as rescue therapy for suspected heparin resistance and recurrent intra-procedural stent thrombosis during complex percutaneous coronary intervention: a case report

CD19-negative non-IgM type lymphoplasmacytic lymphoma: a case report and literature review

Cell surface RNAs define a new interface for immune recognition